Cargando…

High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy

BACKGROUND: Nuclear receptor subfamily 1, group D, member 1 (NR1D1) is a ligand-regulated nuclear receptor and transcriptional factor. Although recent studies have implicated NR1D1 as a regulator of DNA repair and proliferation in breast cancers, its potential as a therapeutic target for breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na, Hyelin, Han, Jinil, Ka, Na-Lee, Lee, Min-Ho, Choi, Yoon-La, Shin, Young Kee, Lee, Mi-Ock
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883674/ https://www.ncbi.nlm.nih.gov/pubmed/31779659 http://dx.doi.org/10.1186/s13058-019-1197-x

Ejemplares similares

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling
por: Ka, Na-Lee, et al.
Publicado: (2023)

MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells
por: Lee, Min-Ho, et al.
Publicado: (2018)

Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients
por: Jeong, Hae Min, et al.
Publicado: (2017)

Trichostatin A enhances acetylation as well as protein stability of ERα through induction of p300 protein
por: Kim, Sung-Hye, et al.
Publicado: (2010)

Pathologic method for extracting good prognosis group in triple‐negative breast cancer after neoadjuvant chemotherapy
por: Eguchi, Yuki, et al.
Publicado: (2022)

BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
por: Jacot, William, et al.
Publicado: (2020)

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2018)

Erratum: Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
por: Shin, Gi Won, et al.
Publicado: (2020)

Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
por: Bae, Soo Youn, et al.
Publicado: (2020)

Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype
por: Yi, Seong Yoon, et al.
Publicado: (2010)

UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer
por: Kim, Yu-Jin, et al.
Publicado: (2020)

Liver-specific deletion of RORα aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction
por: Kim, Hyeon-Ji, et al.
Publicado: (2017)

Nuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancer
por: Wu, Hongmei, et al.
Publicado: (2017)

BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Tanino, Hirokazu, et al.
Publicado: (2016)

High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer
por: Chen, Li, et al.
Publicado: (2021)

Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis
por: Yamashita, Naoki, et al.
Publicado: (2022)

RORα switches transcriptional mode of ERRγ that results in transcriptional repression of CYP2E1 under ethanol-exposure
por: Han, Yong-Hyun, et al.
Publicado: (2016)

Synergistic effects of depression and NR3C1 methylation on prognosis of acute coronary syndrome
por: Kang, Hee-Ju, et al.
Publicado: (2020)

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
por: Ouyang, Mao, et al.
Publicado: (2015)

NR1D1 deficiency in the tumor microenvironment promotes lung tumor development by activating the NLRP3 inflammasome
por: Kim, Sun Mi, et al.
Publicado: (2023)

The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer
por: Lim, Seung Taek, et al.
Publicado: (2018)

SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer
por: Jung, Wonkyung, et al.
Publicado: (2013)

CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy
por: Lemesle, Marine, et al.
Publicado: (2022)

Streichquartett Nr. 1 ; Streichquartett Nr. 2
por: Ligeti, György, 1923-
Publicado: (1988)

Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jung, Yoon Yang, et al.
Publicado: (2016)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
por: Kim, So-Woon, et al.
Publicado: (2021)

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer
por: Pu, Shengyu, et al.
Publicado: (2022)

Suberoylanilide Hydroxamic Acid Attenuates Autoimmune Arthritis by Suppressing Th17 Cells through NR1D1 Inhibition
por: Kim, Da Som, et al.
Publicado: (2019)

Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors
por: Cavara, Nora A, et al.
Publicado: (2009)

Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
por: Hatzipanagiotou, Maria Eleni, et al.
Publicado: (2023)

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

22‐S‐Hydroxycholesterol protects against ethanol‐induced liver injury by blocking the auto/paracrine activation of MCP‐1 mediated by LXRα
por: Na, Tae‐Young, et al.
Publicado: (2015)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
por: Zhou, Qin, et al.
Publicado: (2023)

Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

Biological and clinical significance of flap endonuclease-1 in triple-negative breast cancer: Support of metastasis and a poor prognosis
por: Xu, Lu, et al.
Publicado: (2020)

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
por: Montagna, Emilia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0li3p3vcepce52oakea74qtbok